↓ Direkt till sidans innehåll
↓ Direkt till sidans sekundära innehåll (sidomenyn)

Träfflista för sökning "WFRF:(Lundgren S.) srt2:(2005-2009)"

Sökning: WFRF:(Lundgren S.) > (2005-2009)

Resultat 1-10 av 64

Sortera/gruppera träfflistan

Sortering: Träffar per sida:

Numrering	Referens	Omslagsbild	Hitta
1.	Fox, Z, et al. (författare) Predictors of CD4 count change over 8 months of follow up in HIV-1-infected patients with a CD4 count>or=300 cells/microL who were assigned to 7.5 MIU interleukin-2 2007 Ingår i: HIV medicine. - : Wiley. - 1464-2662 .- 1468-1293. ; 8:2, s. 112-123 Tidskriftsartikel (refereegranskat)
2.	Wilking, N., et al. (författare) Long-term follow-up of the SBG 9401 study comparing tailored FEC-based therapy versus marrow-supported high-dose therapy 2007 Ingår i: Annals of Oncology. - : Elsevier BV. - 0923-7534 .- 1569-8041. ; 18:4, s. 694-700 Tidskriftsartikel (refereegranskat)abstract Background: The purpose was to investigate adjuvant marrow-supportive high-dose chemotherapy compared with an equitoxicity-tailored comparator arm. Patients and methods: Five hundred and twenty-five women below theage of 60 years with operated high-risk primary breast cancer were randomised to nine cycles of granulocyte colony-stimulating factor supported and individually tailored FEC (5-fluorouracil, epirubicin, cyclophosphamide), (n = 251) or standard FEC followed by marrow-supported high-dose therapy with CTCb (cyclophosphamide, thiotepa, carboplatin) therapy (n = 274), followed by locoregional radiotherapy and tamoxifen for 5 years. Results: There were 104 breast cancer relapses in the tailored FEC group versus 139 in the CTCb group (double triangular method by Whitehead, P = 0.046), with a median follow-up of all included patients of 60.8 months. The event-free survival demonstrated 121 and 150 events in the tailored FEC- and CTCb group, respectively [P = 0.074, hazard ratio (HR) 0.804, 95% confidence interval (CI) 0.633-1.022]. Ten patients in the tailored FEC regimen developed acute myeloid leukaemia (AML)/myelodysplasia (MDS). One hundred deaths occurred in the tailored FEC group and 121 in the CTCb group (P = 0.287, HR 0.866, 95% CI 0.665-1.129). Conclusion: The update of this study shows an improved outcome linked to the tailored FEC treatment in relation to breast cancer relapse, but also an increased incidence of AML/MDS. © 2007 Oxford University Press.
3.	Güsten, R., et al. (författare) APEX - The Atacama Pathfinder Experiment 2006 Ingår i: Proceedings of SPIE - The International Society for Optical Engineering. - : SPIE. - 0277-786X .- 1996-756X. ; 6267 I Konferensbidrag (refereegranskat)abstract APEX, the Atacama Pathfinder Experiment, has been successfully commissioned and is in operation now. This novel submillimeter telescope is located at 5107 m altitude on Llano de Chajnantor in the Chilean High Andes, on what is considered one of the world's outstanding sites for submillimeter astronomy. The primary reflector with 12 m diameter has been carefully adjusted by means of holography. Its surface smoothness of 17-18 μm makes APEX suitable for observations up to 200 μm, through all atmospheric submm windows accessible from the ground.
4.	Yeni, P, et al. (författare) Virological and immunological outcomes at 3 years after starting antiretroviral therapy with regimens containing non-nucleoside reverse transcriptase inhibitor, protease inhibitor, or both in INITIO: open-label randomised trial 2006 Ingår i: Lancet (London, England). - 1474-547X. ; 368:9532, s. 287-298 Tidskriftsartikel (refereegranskat)
5.	Alberti, A, et al. (författare) Short statement of the first European Consensus Conference on the treatment of chronic hepatitis B and C in HIV co-infected patients 2005 Ingår i: Journal of hepatology. - : Elsevier BV. - 0168-8278. ; 42:5, s. 615-624 Tidskriftsartikel (refereegranskat)
6.	Alberti, A, et al. (författare) Short statement of the first european consensus conference on the treatment of chronic hepatitis B and C in HIV co-infected patients (vol 42, pg 615, 2005) 2005 Ingår i: JOURNAL OF HEPATOLOGY. - : Elsevier BV. - 0168-8278. ; 43:6, s. 1098-1098 Tidskriftsartikel (övrigt vetenskapligt/konstnärligt)
7.	Dueland, S., et al. (författare) a multicentre, phase ii study of cp-4055 in combination with sorafenib in patients with metastatic malignant melanoma 2008 Ingår i: Annals of Oncology. - 1569-8041. ; 19, s. 245-246 Konferensbidrag (refereegranskat)
8.	Hartter, S, et al. (författare) Effect of caffeine intake 12 or 24 hours prior to melatonin intake and CYP1A21F polymorphism on CYP1A2 phenotyping by melatonin 2006 Ingår i:* Basic & clinical pharmacology & toxicology. - : Wiley. - 1742-7835. ; 99:4, s. 300-304 Tidskriftsartikel (refereegranskat)
9.	Hodgins, S, et al. (författare) Consulting for substance abuse: mental disorders among adolescents and their parents 2007 Ingår i: Nordic journal of psychiatry. - : Informa UK Limited. - 0803-9488 .- 1502-4725. ; 61:5, s. 379-386 Tidskriftsartikel (refereegranskat)
10.	Lundgren, T, et al. (författare) Impaired cytotoxicity in Papillon-Lefèvre syndrome 2005 Ingår i: Journal of Dental Research. - 0022-0345 .- 1544-0591. ; 84:5, s. 414-417 Tidskriftsartikel (refereegranskat)abstract Papillon-Lefèvre syndrome (PLS), palmoplantar hyperkeratosis with periodontitis, has been genetically characterized. However, suspected associated immune dysfunctions remain elusive. The purpose of this study was to evaluate peripheral blood lymphocyte levels and natural killer (NK) cell cytotoxicity in PLS. Twenty patients and 20 healthy controls were examined. Peripheral blood lymphocytes were analyzed by flow cytometry for surface markers. NK cell cytotoxicity against K562 cells was determined by means of a 51Cr release assay. White blood cell differential and proportions of B-, T-, T-helper, T-suppressor, and NK cells revealed only sporadic borderline variations from control values. In contrast, NK cell cytotoxicity was consistently and severely depressed (32-53% of control values) in all patients. To the best of our knowledge, this newly described impairment of NK cell cytotoxic function is the first consistent immune dysfunction reported in PLS. This suggests that the impaired NK cell cytotoxicity might contribute to the pathogenesis of PLS-associated periodontitis.

Skapa referenser, mejla, bekava och länka

Länka till träfflistan

Resultat 1-10 av 64

Avgränsa träffmängd

Typ av publikation: tidskriftsartikel (49); konferensbidrag (13); rapport (1); bok (1)

Typ av innehåll: refereegranskat (52); övrigt vetenskapligt/konstnärligt (12)

Författare/redaktör: Lundgren, S (21); Lundgren, Edvin (7); Lundgren, J (7); Reiss, P (5); LUNDGREN, JD (5); Hassan, M (4); visa fler...; Clumeck, N (4); Afsharian, P (4); Bergh, J (3); Preobrajenski, Alexe ... (3); Lundgren, T (3); Erikstein, B (3); Ingelman-Sundberg, M (3); Mårtensson, Nils (3); Flood, Lennart, 1952 (2); Vogel, M. (2); Wang, J. (2); Becker, S. (2); Weber, J. (2); Sonnerborg, A (2); Weber, R. (2); Ferrer, S. (2); Collins, S (2); Sandstrom, E (2); Aboulker, JP (2); Babiker, A (2); Darbyshire, JH (2); Cooper, DA (2); Gatell, J (2); Abrams, D (2); Antunes, F (2); Katlama, C (2); Darbyshire, J (2); Alberti, A. (2); Weiland, O (2); Andersen, Jesper N (2); Mulcahy, F (2); Terelius, Y (2); Ahlberg, A (2); Lagerlund, M (2); Friesland, S (2); Vinogradov, A. S. (2); Blaxhult, A (2); Auer, G (2); Gerlich, W (2); Palu, G (2); Thiebaut, R (2); Yazdanpanah, Y (2); Zeuzem, S (2); Olofsson, Hans, 1952 (2); visa färre...

Lärosäte: Karolinska Institutet (38); Lunds universitet (11); Uppsala universitet (6); Göteborgs universitet (4); Umeå universitet (3); Stockholms universitet (3); visa fler...; Linköpings universitet (3); Chalmers tekniska högskola (3); Högskolan Kristianstad (2); Luleå tekniska universitet (2); Malmö universitet (2); Kungliga Tekniska Högskolan (1); Högskolan i Halmstad (1); Linnéuniversitetet (1); visa färre...

Språk: Engelska (62); Svenska (2)

Forskningsämne (UKÄ/SCB): Naturvetenskap (9); Medicin och hälsovetenskap (9); Teknik (3); Samhällsvetenskap (2)

År

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

Copyright © LIBRIS - Nationella bibliotekssystem
LIBRIS.kb.se

pil uppåt

Stäng

Kopiera och spara länken för att återkomma till aktuell vy